Drug Pipeline

Palifermin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1/2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT01746849 Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total… Leukemia Active, Not Recruiting
NCT07582172 Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as… Acute Myeloid Leukemia With Complex Karyotype Not Yet Recruiting
Phase 1/2
NCT06959771 Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome… CD40L-HyperIgM Syndrome Recruiting
NCT01306019 Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With… X-linked Severe Combined Immunodeficiency (XSCID) Recruiting
NCT06325709 Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked… Chronic Granulomatous Disease (CGD) Recruiting
NCT06851767 Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency… X-linked Severe Combined Immunodeficiency Enrolling by Invitation
Phase 1
NCT04177004 Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With… Allogeneic Hematopoietic Stem Cell Transplant Recipient Active, Not Recruiting
Sponsors Running Palifermin Trials
Disease Areas
Get alerts when Palifermin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free